Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yuan Gao, Ann‐Lii Cheng, Lee X. Li, Natalie Parent, Ganessan Kichenadasse, Christos S. Karapetis, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	International Journal of Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet